Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation
Il Han Kim
Radiat Oncol J. 2019;37(1):1-12. Published online 2019 Mar 31 DOI: https://doi.org/10.3857/roj.2019.00171
|
Citations to this article as recorded by
Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02)
Dowook Kim, Joo Ho Lee, Nalee Kim, Do Hoon Lim, Jin Ho Song, Chang-Ok Suh, Chan Woo Wee, In Ah Kim
Neurosurgery.2024;[Epub] CrossRef Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse
Elissa Tong, Patrick Horsley, Helen Wheeler, Matthew Wong, Venkatesha Venkatesha, Joseph Chan, Marina Kastelan, Michael Back
Journal of Neuro-Oncology.2024; 168(1): 69. CrossRef Dosimetric Evaluations of HyperArc and RapidArc in Stereotactic Radiosurgery for a Single Brain Metastasis
So-Yeon Park, Noorie Choi, Na Young Jang
Progress in Medical Physics.2024; 35(2): 36. CrossRef Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
Minjie Fu, Zhirui Zhou, Xiao Huang, Zhenchao Chen, Licheng Zhang, Jinsen Zhang, Wei Hua, Ying Mao
BMC Cancer.2023;[Epub] CrossRef PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
Mengjie Zhao, Yanhui Li, Chenfei Lu, Fangshu Ding, Miao Xu, Xin Ge, Mengdie Li, Zhen Wang, Jianxing Yin, Junxia Zhang, Xiefeng Wang, Zehe Ge, Hong Xiao, Yong Xiao, Hongyi Liu, Wentao Liu, Yuandong Cao, Qianghu Wang, Yongping You, Xiuxing Wang, Kun Yang, Z
Cancer Research.2023; 83(7): 1094. CrossRef Diallyl trisulfide sensitizes radiation therapy on glioblastoma through directly targeting thioredoxin 1
Yangyang Tian, Zehe Ge, Miao Xu, Xin Ge, Mengjie Zhao, Fangshu Ding, Jianxing Yin, Xiuxing Wang, Yongping You, Zhumei Shi, Xu Qian
Free Radical Biology and Medicine.2022; 189: 157. CrossRef Bevacizumab combined with re-irradiation in recurrent glioblastoma
Lei She, Lin Su, Chao Liu
Frontiers in Oncology.2022;[Epub] CrossRef Exploration of biomedical knowledge for recurrent glioblastoma using natural language processing deep learning models
Bum-Sup Jang, Andrew J. Park, In Ah Kim
BMC Medical Informatics and Decision Making.2022;[Epub] CrossRef Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective study
Nicolas Demogeot, J. Salleron, F. Rech, L. Taillandier, P. Royer, G. Vogin
Radiation Oncology.2022;[Epub] CrossRef Value of a 18F-FDG PET/CT Semi-quantitative Parameter (SUVmax) in Predicting the Survival of Patients with Esophageal Cancer Subtypes
Hemmat Ebrat Balkhkanlou, Abtin Doroudinia, Mehrdad Bakhshayesh Karam, Habib Emami
Iranian Journal of Radiology.2022;[Epub] CrossRef Treatment options for progression or recurrence of glioblastoma: a network meta-analysis
Catherine McBain, Theresa A Lawrie, Ewelina Rogozińska, Ashleigh Kernohan, Tomos Robinson, Sarah Jefferies
Cochrane Database of Systematic Reviews.2021;[Epub] CrossRef Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma
Donatella Arpa, Elisabetta Parisi, Giulia Ghigi, Annalisa Cortesi, Pasquale Longobardi, Patrizia Cenni, Martina Pieri, Luca Tontini, Elisa Neri, Simona Micheletti, Francesca Ghetti, Manuela Monti, Flavia Foca, Anna Tesei, Chiara Arienti, Anna Sarnelli, Gi
Frontiers in Oncology.2021;[Epub] CrossRef Frameless immobilization system with roll correction for stereotactic radiosurgery of intracranial brain metastases
So-Yeon Park, Noorie Choi, Na Young Jang
Journal of Radiation Research.2021;[Epub] CrossRef
|